Literature DB >> 17544401

Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy.

Muhammed Z Cader1, Jingshan Ren, Paul A James, Louise E Bird, Kevin Talbot, David K Stammers.   

Abstract

Dominant mutations in the ubiquitous enzyme glycyl-tRNA synthetase (GlyRS), including S581L, lead to motor nerve degeneration. We have determined crystal structures of wildtype and S581L-mutant human GlyRS. The S581L mutation is approximately 50A from the active site, and yet gives reduced aminoacylation activity. The overall structures of wildtype and S581L-GlyRS, including the active site, are very similar. However, residues 567-575 of the anticodon-binding domain shift position and in turn could indirectly affect glycine binding via the tRNA or alternatively inhibit conformational changes. Reduced enzyme activity may underlie neuronal degeneration, although a dominant-negative effect is more likely in this autosomal dominant disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544401     DOI: 10.1016/j.febslet.2007.05.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).

Authors:  Heather M McLaughlin; Reiko Sakaguchi; William Giblin; Thomas E Wilson; Leslie Biesecker; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Yi-Chung Lee; Marina Kennerson; Ya-Ming Hou; Garth Nicholson; Anthony Antonellis
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

Review 2.  Aminoacyl tRNA synthetases and their connections to disease.

Authors:  Sang Gyu Park; Paul Schimmel; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

3.  Expansion of the QARS deficiency phenotype with report of a family with isolated supratentorial brain abnormalities.

Authors:  Ramona Salvarinova; Cynthia X Ye; Andrea Rossi; Roberta Biancheri; Elke H Roland; Paul Pavlidis; Colin J Ross; Maja Tarailo-Graovac; Wyeth W Wasserman; Clara D M van Karnebeek
Journal:  Neurogenetics       Date:  2014-11-30       Impact factor: 2.660

4.  Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.

Authors:  Weiwei He; Hui-Min Zhang; Yeeting E Chong; Min Guo; Alan G Marshall; Xiang-Lei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

5.  A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.

Authors:  Aimée Vester; Gisselle Velez-Ruiz; Heather M McLaughlin; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Ricardo H Roda; Kenneth H Fischbeck; Leslie G Biesecker; Garth Nicholson; Asim A Beg; Anthony Antonellis
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

Review 6.  Emergence and evolution.

Authors:  Tammy J Bullwinkle; Michael Ibba
Journal:  Top Curr Chem       Date:  2014

7.  The crystal structures of the α-subunit of the α(2)β (2) tetrameric Glycyl-tRNA synthetase.

Authors:  Kemin Tan; Min Zhou; Rongguang Zhang; Wayne F Anderson; Andrzej Joachimiak
Journal:  J Struct Funct Genomics       Date:  2012-10-06

8.  A novel endogenous damage signal, glycyl tRNA synthetase, activates multiple beneficial functions of mesenchymal stem cells.

Authors:  Se-Ra Park; Hyun-Jin Kim; Se-Ran Yang; Chan Hum Park; Hwa-Yong Lee; In-Sun Hong
Journal:  Cell Death Differ       Date:  2018-04-17       Impact factor: 15.828

Review 9.  Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.

Authors:  Na Wei; Qian Zhang; Xiang-Lei Yang
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

10.  Crystal structures and biochemical analyses suggest a unique mechanism and role for human glycyl-tRNA synthetase in Ap4A homeostasis.

Authors:  Rey-Ting Guo; Yeeting E Chong; Min Guo; Xiang-Lei Yang
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.